Vir Biotechnology, Inc. Uncategorized Contracts & Agreements

23 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement between the Company and Glaxo Wellcome UK Limited, dated February 21, 2024
Vir Biotechnology, Inc.
Biotechnology
2024
Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated January 12, 2022
Vir Biotechnology, Inc.
Biotechnology
2022
Amended and Restated Letter Agreement between the Company and the Bill & Melinda Gates Foundation, dated January 12, 2022
Vir Biotechnology, Inc.
Biotechnology
WA
2022
Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated November 5, 2021
Vir Biotechnology, Inc.
Biotechnology
2022
Amendment No. 5 to Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated December 8, 2021
Vir Biotechnology, Inc.
Biotechnology
2022
Amendment No. 4 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated December 8, 2020
Vir Biotechnology, Inc.
Biotechnology
2021
Amendment No. 3 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated May 22, 2020
Vir Biotechnology, Inc.
Biotechnology
2021
Letter Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated December 23, 2020
Vir Biotechnology, Inc.
Biotechnology
2021
Promotion Letter Agreement between the Company and Steven Rice, dated July 30, 2020
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 3 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated May 29, 2020
Vir Biotechnology, Inc.
Biotechnology
2020
Letter of Intent between the Company and Wuxi Biologics (Hong Kong) Limited, dated June 15, 2020
Vir Biotechnology, Inc.
Biotechnology
2020
Binding Letter Agreement between the Company and Samsung Biologics Co., Ltd., dated April 9, 2020
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 2 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated October 28, 2019
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 1 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated April 22, 2019
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 2 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated February 24, 2020
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 1 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated April 18, 2019
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment Agreement between the Registrant (as successor in interest to Humabs BioMed SA) and the Institute for Research in Biomedicine, dated January 29, 2018
Vir Biotechnology, Inc.
Biotechnology
2019
Grant Agreement between the Registrant and the Bill & Melinda Gates Foundation, dated March 16, 2018
Vir Biotechnology, Inc.
Biotechnology
2019
Grant Agreement between the Registrant and the Bill & Melinda Gates Foundation, dated January 26, 2018
Vir Biotechnology, Inc.
Biotechnology
2019
Letter Agreement between the Registrant and the Bill & Melinda Gates Foundation, dated December 23, 2016
Vir Biotechnology, Inc.
Biotechnology
WA
2019
Letter Agreement between the Registrant and the stockholders of TomegaVax, Inc. set forth therein, dated September 12, 2016
Vir Biotechnology, Inc.
Biotechnology
2019
Letter Agreement between the Registrant and Alnylam Pharmaceuticals, Inc., dated November 13, 2018
Vir Biotechnology, Inc.
Biotechnology
2019
Form of Indemnity Agreement by and between the Registrant and its directors and executive officers
Vir Biotechnology, Inc.
Biotechnology
DE
2019